Generative AI and the De Novo Revolution in Antibody Discovery

added blog Wellness

2025-12-19 12:55:55 -

The integration of artificial intelligence is no longer an optional upgrade but a fundamental requirement for competitive drug discovery. An updated Antibody Drug Discovery Market Trend report reveals that AI/ML-enabled platforms are forecast to expand at a staggering 22.4% CAGR between 2025 and 2030. In June 2025, the unveiling of Chai-2—a generative AI model reporting 16% de novo...

0 Comments 0 Shares 4K Views 0 Reviews